Distributive Shock Overview

Aug 22, 2025

Overview

This lecture focuses on distributive shock, specifically sepsis and anaphylaxis, covering their pathophysiology, clinical presentation, and emergency management.

Distributive Shock: Pathophysiology and General Features

  • Distributive shock (vasodilatory shock) involves widespread vasodilation and maldistribution of intravascular volume.
  • Leads to decreased cardiac output and impaired tissue perfusion.
  • Main subtypes discussed: sepsis and anaphylaxis.

Sepsis and Systemic Inflammatory Response Syndrome (SIRS)

  • SIRS is a systemic inflammatory response triggered by infection entering through skin, respiratory, GI, or GU tracts.
  • SIRS criteria: temp <36°C or >38°C, HR >90, RR >20 or PaCO2 <32, WBC <4,000 or >12,000, bands >10%.
  • Sepsis = SIRS + suspected/confirmed infection.
  • Severe sepsis: sepsis with organ dysfunction; septic shock: refractory hypotension.
  • Untreated, progression can lead to MODS (multi-organ dysfunction syndrome) and death.

Sepsis Management and Prevention

  • Prevention: sterile technique for lines, catheter care, remove unnecessary lines promptly.
  • Early recognition and intervention are key.
  • Start with two large-bore IVs (IO if necessary); obtain cultures before antibiotics.
  • Blood, urine, and wound cultures from different sites 15 minutes apart.
  • Lactic acid >2 mmol/L is elevated; >4 mmol/L is poor prognosis.
  • Complete initial assessments and interventions ideally within 1 hour; official window is 3 hours.
  • Remove and culture indwelling catheters/lines present before symptoms.
  • Interventions: oxygen, 30 mL/kg fluid bolus, vasopressors if fluids ineffective, repeat lactic acid after fluids.
  • Fluid challenge: raise patient's feet and observe BP response.

Anaphylaxis: Causes and Pathophysiology

  • Anaphylaxis is an acute allergic reaction caused by food, medications, insect stings, latex, or environmental triggers.
  • IgE-mediated response activates mast cells, releasing histamine, eosinophils, prostaglandins.
  • Histamine causes vasodilation, edema, pruritus, bronchospasm.
  • Antihistamines used: diphenhydramine for H1, famotidine/pepsid for H2.
  • Severity varies among individuals; first exposure may be mild, subsequent exposures more severe.
  • Allergies can be hereditary; teach patients to avoid triggers and carry/use EpiPen.

Anaphylaxis Presentation and Management

  • Mild: within 2 hours; nasal congestion, hives, tingling, warmth.
  • Moderate: same as mild plus flushing, anxiety, coughing, airway edema, wheezing.
  • Severe: within minutes; bronchospasm, airway closure, cyanosis, stridor, hypotension, GI symptoms, possible cardiac arrest.
  • Monitor patients receiving epinephrine for tachycardia and recurrence (possible within 48 hours).
  • Epi dosing: 0.3 mg IM (1:1,000) for adults; 0.01 mg/kg IM for children.
  • Only give IV epi (1:10,000) if patient is coding.
  • Adjunct medications: corticosteroids (solumedrol), diphenhydramine, famotidine/pepsid.

Key Terms & Definitions

  • Distributive Shock — Shock from abnormal blood distribution due to vasodilation.
  • Sepsis — Life-threatening organ dysfunction from a dysregulated infection response.
  • SIRS — Systemic response to infection or inflammation.
  • MODS — Multi-organ dysfunction syndrome; failure of two or more organ systems.
  • Anaphylaxis — Severe, rapid allergic reaction causing systemic symptoms.
  • IgE — Immunoglobulin involved in allergic responses and anaphylaxis.
  • Histamine — Chemical mediator causing vasodilation and bronchospasm.

Action Items / Next Steps

  • Review SIRS criteria and practice identifying sepsis.
  • Review anaphylaxis management steps, including EpiPen use.
  • Practice sterile technique skills for line and catheter care where applicable.
  • Prepare for a separate neurogenic shock lecture.